PaulKlenermanLab retweeted
Pressure to publish jumps. And researchers have no time to do science.
(New survey from Elsevier)
Survey of 3200 researchers:
1. Only 45% of scientists have sufficient time for actual research.
2. For 68%, the pressure to publish today is greater than 2-3 years ago.
3. 29% of researchers are considering relocating to another country (for better funding, work‐life balance, or greater research freedom).
4. 58% of researchers use AI tools in their work.
5. Reported benefits from AI: saving time (58%), helping with literature summaries (61%), literature reviews (51%), data analysis (38%), drafting proposals (41%), and drafting papers (38%).
Globally, life in academia is getting worse.
For students & postdocs - it’s especially hard to decide on an academic career.
❗️ A few days ago, I gave a lecture on this topic.
“PhD: Dreams, Reality and Consequences”
Watch it here: lnkd.in/dA_GhYwd
(I’ll appreciate if you ‘like’ this video - you will GREATLY help it reach more students.)
PaulKlenermanLab retweeted
A new study finds that extended intervals between #SARSCoV2 mRNA vaccine doses lead to higher quality T cell responses and lower inflammation after vaccination in humans.
Learn more in @SciImmunology: scim.ag/3HTbCnm
PaulKlenermanLab retweeted
Very happy to share the latest work out in @SciImmunology. Here we use single cell RNA-sequencing in combination with an activation induced marker (AIM) assay to explore the impact of the COVID-19 vaccine regimen on T cell quality. With @PKlenermanLab @nprovine @NDMOxford
A new study finds that extended intervals between #SARSCoV2 mRNA vaccine doses lead to higher quality T cell responses and lower inflammation after vaccination in humans.
Learn more in @SciImmunology: scim.ag/3HTbCnm
PaulKlenermanLab retweeted
And please check out it's sister paper also at @SciImmunology, led by the brilliant @aliamini419 and @TheLucyGarner.
scim.ag/3JD7fgO
PaulKlenermanLab retweeted
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines
science.org/doi/10.1126/scii… @SciImmunology @PKlenermanLab @aliamini419 @TheLucyGarner @nprovine 🇬🇧
PaulKlenermanLab retweeted
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines @SciImmunology @PKlenermanLab @nprovine 🇬🇧
science.org/doi/10.1126/scii…
PaulKlenermanLab retweeted
It was a delight to contribute to the @EASLedu Basic Science School @TGU_Oxford & deliver the state-of-the-art lecture. Thanks to all faculty (@TamCarg @EmmaCulver6 @PKlenermanLab @EleanorBarnesOx) & EASL. Happy to collaborate for work on FNA's! @blizard_inst @BartsHepatology
It was an honour to host the @EASLedu Basic Science School at the TGLU Oxford @TGU_Oxford @NDMOxford with a brilliant keynote from @druppygill and lots of hands on learning in the lab. Great to connect with delegates from across the world @DavidTrampert @DraMartaAlonsoP
PaulKlenermanLab retweeted
Our upcoming EASL Basic Science School will introduce you to advanced immunological techniques as applied to translational hepatology research.
These experimental hands-on sessions will be led by organisers @EleanorBarnesOx, Paul Klenerman, @EmmaCulver6, @TamCarg, @tom_marjot, and @RoryPeters16.
Apply by 30 September: easl.eu/event/basic-science-…
#LiverTwitter @PKlenermanLab
PaulKlenermanLab retweeted
Replying to @Leo1401j @bsicongress
@PKlenermanLab indoctrination worked a charm! Need a solid petition now to get this over the line.
PaulKlenermanLab retweeted
On Thursday 25th April, we celebrated the kind donation of Sir Peter Medawar’s Nobel Prize medal, to inspire good science at Oxford: immunology.ox.ac.uk/news/unv… @OxfordBiology @Dunn_School @NDMOxford @OxfordMedSci @PKlenermanLab @fgissa @NDSurgicalSci
PaulKlenermanLab retweeted
Some people on the @Bioconductor forum are really rude when answering questions. If you don't want to help, maybe just don't respond, rather than treating people like they are idiots! #Bioinformatics #academia
PaulKlenermanLab retweeted
Inspiring and thought-provoking session with @PKlenermanLab and @ZakiyaLeeming from @rncmlive at @sim_manchester to launch the science strand of our #T4TM project. More information on the project here: immunology.ox.ac.uk/about/pu… – at North West, England
Our science workshop for the Thanks for the Memories project has kicked off! #T4TM
@CoopAcademies students are working with @RNCMPRiSM and @UniofOxford to compose music inspired by immunology.
Welcoming students from @WalkdenCoop @coopfailsworth @CoopAcademyNM @CoopManchester
PaulKlenermanLab retweeted
Huge congratulations and thank you for allowing me to contribute in a small way to this fantastic study @rmassonix and @hoheyn cell.com/immunity/fulltext/S…
PaulKlenermanLab retweeted
📣Just 1 week left to submit your abstract for the @BSI_Oxford & @OxImmuno symposium
#OIS24 will showcase diverse disciplines & technologies incl. fundamental #biology, #infection & imaging, systems #immunology, therapeutics & #AI 👏
Submit by Mon 5 Feb🔗bit.ly/46W0rkq
PaulKlenermanLab retweeted
MIT University released free online courses.
No textbooks or fees required.
Here are 10 courses you don't want to miss:
Very interesting paper on the effect of N1-methylpseudouridylation of mRNA on translation fidelity nature.com/articles/s41586-0…
PaulKlenermanLab retweeted
Our review by PITCH investigators @rebecca37704429 Lulu Wang, @Alex_MRCDiMeN @LanceTurtle @AlexRichter3 @chrisjaduncan @Susannajd @PKlenermanLab on T cell immune memory after covid-19 and vaccination is now out! bmjmedicine.bmj.com/content/…
PaulKlenermanLab retweeted
Next speaker: the Sidney Truelove professor of Gastroenterology @PKlenermanLab, with "A tale of two papers" - and stories about vaccine research and liver resident cells that increased our understanding of defences for liver infection
PaulKlenermanLab retweeted
Has anyone tested different RNase inhibitors with the 10x Genomics multiome protocol? The recommended Protector RNase Inhibitor from Merck is currently backordered. #scRNAseq @10xGenomics
































